SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-021018
Filing Date
2018-08-09
Accepted
2018-08-09 16:01:51
Documents
61
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q spro-10q_20180630.htm 10-Q 2274354
2 EX-31.1 spro-ex311_7.htm EX-31.1 18290
3 EX-31.2 spro-ex312_6.htm EX-31.2 18486
4 EX-32.1 spro-ex321_8.htm EX-32.1 9821
5 EX-32.2 spro-ex322_9.htm EX-32.2 9838
  Complete submission text file 0001564590-18-021018.txt   7072752

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT spro-20180630.xml EX-101.INS 1310414
7 XBRL TAXONOMY EXTENSION SCHEMA spro-20180630.xsd EX-101.SCH 58596
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE spro-20180630_cal.xml EX-101.CAL 46918
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE spro-20180630_def.xml EX-101.DEF 230212
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE spro-20180630_lab.xml EX-101.LAB 394552
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE spro-20180630_pre.xml EX-101.PRE 333827
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38266 | Film No.: 181004934
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences